Deals, Partnering

Accumetrics, Daiichi Sankyo and Eli Lilly launch strategic U.S. collaboration

Posted on 12 July 2010

Tags: , ,

Accumetrics, Inc., Daiichi Sankyo, Inc, and Eli Lilly and Company announced today that the companies have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of platelet function testing.

Several factors, including a patient's genetic make-up, diabetic status, age, weight and the use of certain other medications metabolized through the cytochrome P450 pathway in the body may influence patient response to antiplatelet medicines. Therefore, it is important that physicians understand their options to determine if their use of a specific antiplatelet medicine is having its intended effect. Read the full story on the new collaboration here

Print Friendly, PDF & Email

Leave a Reply